Placental stem/progenitor cells: Isolation and characterization

Perinatal Stem Cells

Volumn , Issue , 2014, Pages 141-157

  Parolini, Ornella ^a   De, Debashree ^a   Rodrigues, Melissa ^a   Caruso, Maddalena ^a  

^a Istituto Ospedaliero   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929746739     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1118-9_13     Document Type: Chapter

References (159)

1. Varney H, Kriebs JM, Gegor CL. Varney's Midwifery. 4th ed. Sudbury, MA: Jones and Bartlett; 2004.
2. Moore KL, Persaud TVN. The developing human. 6th ed. Philadelphia: WB Saunders Company; 1998.
3. Lewis HS, Benirschhke K. Placenta. In: Sternberg SS, editor. Histology for pathologists. 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 961-94.
4. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of thefirst international workshop on placenta derived stem cells. Stem Cells. 2008;26(2):300-11.
5. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, et al. Placental mesenchymal stem cells as potential autologous graft for pre-and perinatal neuroregeneration. Am J Obstet Gynecol. 2006;194(3):664-73.
6. Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy. 2004;6(6):543-53.
7. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004;22(5):649-58.
8. Castrechini NM, Murthi P, Gude NM, Erwich JJ, Gronthos S, Zannettino A, et al. Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche. Placenta. 2010;31(3): 203-12.
9. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22(7):1338-45.
10. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26(3):591-9.
11. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23(10):1549-59.
12. Murphy S, Rosli S, Acharya R, Mathias L, Lim R, Wallace E, et al. Amnion epithelial cell isolation and characterization for clinical use. Curr Protoc Stem Cell Biol. 2010;Chapter 1:Unit 1E 6.
13. Pratama G, Vaghjiani V, Tee JY, Liu YH, Chan J, Tan C, et al. Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS One. 2011;6(11):e26136.
14. Niknejad H, Deihim T, Peirovi H, Abolghasemi H. Serum-free cryopreservation of human amniotic epithelial cells before and after isolation from their natural scaffold. Cryobiology. 2013;67(1):56-63.
15. Rooney IA, Morgan BP. Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins. Immunology. 1990;71(3):308-11.
16. Bilic G, Ochsenbein-Kolble N, Hall H, Huch R, Zimmermann R. In vitro lesion repair by human amnion epithelial and mesenchymal cells. Am J Obstet Gynecol. 2004;190(1):87-92.
17. Barbati A, Grazia Mameli M, Sidoni A, Di Renzo GC. Amniotic membrane: separation of amniotic mesoderm from amniotic epithelium and isolation of their respective mesenchymal stromal and epithelial cells. Curr Protoc Stem Cell Biol. 2012;Chapter 1:Unit 1E 8.
18. Miki T, Marongiu F, Ellis E, Strom SC. Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol. 2007;Chapter 1:Unit 1E 3.
19. Niknejad H, Peirovi H, Ahmadiani A, Ghanavi J, Jorjani M. Differentiation factors that influence neuronal markers expression in vitro from human amniotic epithelial cells. Eur Cell Mater. 2010;19:22-9.
20. Gillaux C, Mehats C, Vaiman D, Cabrol D, Breuiller-Fouche M. Functional screening of TLRs in human amniotic epithelial cells. J Immunol. 2011;187(5):2766-74.
21. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77(3):577-88.
22. Manuelpillai U, Moodley Y, Borlongan CV, Parolini O. Amniotic membrane and amniotic cells: potential therapeutic tools to combat tissue inflammation andfibrosis? Placenta. 2011;32 Suppl 4:S320-5.
23. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1(4): 296-305.
24. Sudo K, Kanno M, Miharada K, Ogawa S, Hiroyama T, Saijo K, et al. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primaryfibroblast-like cell populations. Stem Cells. 2007;25(7):1610-7.
25. Marongiu F, Gramignoli R, Miki T, Ranade A, Ellis E, Dorko K, et al. Amniotic epithelial stem cells in regenerative medicine. In: Cetrulo CL, Cetrulo KJ, Cetrulo CL, editors. Perinatal stem cells. 1st ed. Hoboken, NJ: Wiley; 2010. p. 159-67.
26. Miki T, Marongiu F, Dorko K, Ellis EC, Strom SC. Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol. 2010;Chapter 1:Unit 1E 3.
27. Abdulrazzak H, Moschidou D, Jones G, Guillot PV. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface. 2010;7 Suppl 6:S689-706.
28. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2006;2(2):133-42.
29. Alcaraz A, Mrowiec A, Insausti CL, Garcia-Vizcaino EM, Ruiz-Canada C, Lopez-Martinez MC, et al. Autocrine TGF-beta induces epithelial to mesenchymal transition in human amniotic epithelial cells. Cell Transplant. 2013;22(8):1351-67.
30. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, Williams ED, et al. Human amnion epithelial cell transplantation abrogates lungfibrosis and augments repair. Am J Respir Crit Care Med. 2010;182(5):643-51.
31. Marcus AJ, Woodbury D. Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med. 2008;12(3):730-42.
32. Miki T. Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther. 2011;2(3):25-35.
33. Diaz-Prado S, Muinos-Lopez E, Hermida-Gomez T, Rendal-Vazquez ME, Fuentes-Boquete I, de Toro FJ, et al. Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem. 2010;111(4):846-57.
34. Mihu CM, Mihu D, Costin N, Rus Ciuca D, Susman S, Ciortea R. Isolation and characterization of stem cells from the placenta and the umbilical cord. Rom J Morphol Embryol. 2008;49(4):441-6.
35. Evangelista M, Soncini M, Parolini O. Placenta-derived stem cells: new hope for cell therapy? Cytotechnology. 2008;58(1): 33-42.
36. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant. 2008;17(8):955-68.
37. Stadler G, Hennerbichler S, Lindenmair A, Peterbauer A, Hofer K, van Griensven M, et al. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy. 2008;10(7):743-52.
38. Sakuragawa N, Thangavel R, Mizuguchi M, Hirasawa M, Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett. 1996;209(1):9-12.
39. Ishii T, Ohsugi K, Nakamura S, Sato K, Hashimoto M, Mikoshiba K, et al. Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system. Neurosci Lett. 1999;268(3):131-4.
40. Elwan MA, Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport. 1997;8(16):3435-8.
41. Elwan MA. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells. Eur J Pharmacol. 1998;354(1):R1-2.
42. Kakishita K, Nakao N, Sakuragawa N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 2003;980(1):48-56.
43. Liu T, Wu J, Huang Q, Hou Y, Jiang Z, Zang S, et al. Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock. 2008;29(5):603-11.
44. Wu ZY, Hui GZ, Lu Y, Wu X, Guo LH. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin Med J (Engl). 2006;119(24):2101-7.
45. Liu YH, Vaghjiani V, Tee JY, To K, Cui P, Oh DY, et al. Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One. 2012;7(4):e35758.
46. McDonald C, Siatskas C, Bernard CCA. The emergence of amnion epithelial stem cells for the treatment of Multiple Sclerosis. Inflamm Regen. 2011;31(3):256-71.
47. Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, Sakuragawa N. Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res. 2000;62(4): 585-90.
48. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, Tashiro T, Okuyama T, et al. Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J Hum Genet. 2000;45(3):171-6.
49. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct. 2004;29(3):73-84.
50. Marongiu F, Gramignoli R, Dorko K, Miki T, Ranade AR, Paola Serra M, et al. Hepatic differentiation of amniotic epithelial cells. Hepatology. 2011;53(5):1719-29.
51. Tee JY, Vaghjiani V, Liu YH, Murthi P, Chan J, Manuelpillai U. Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells. Curr Stem Cell Res Ther. 2013;8(1):91-9.
52. Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, Liu A, et al. Transplantation of human amnion epithelial cells reduces hepaticfibrosis in immunocompetent CCl(4)-treated mice. Cell Transplant. 2010;19(9):1157-68.
53. Manuelpillai U, Lourensz D, Vaghjiani V, Tchongue J, Lacey D, Tee JY, et al. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepaticfibrosis. PLoS One. 2012;7(6):e38631.
54. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, et al. Human amnion-isolated cells normalize blood glucose in streptozotocininduced diabetic mice. Cell Transplant. 2003;12(5):545-52.
55. Hou Y, Huang Q, Liu T, Guo L. Human amnion epithelial cells can be induced to differentiate into functional insulin-producing cells. Acta Biochim Biophys Sin. 2008;40(9):830-9.
56. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, Albertini A, Parolini O. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant. 2009;18(10):1147-59.
57. Cargnoni A, Ressel L, Rossi D, Poli A, Arienti D, Lombardi G, et al. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lungfibrosis. Cytotherapy. 2012;14(2):153-61.
58. Tamagawa T, Ishiwata I, Nakamura Y. Differentiation of human amniotic membrane cells into osteoblasts in vitro. Hum Cell. 2005;18(4):191-5.
59. Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12-25.
60. Brooke G, Rossetti T, Pelekanos R, Ilic N, Murray P, Hancock S, et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol. 2009;144(4):571-9.
61. Pipino C, Shangaris P, Resca E, Zia S, Deprest J, Sebire NJ, et al. Placenta as a reservoir of stem cells: an underutilized resource? Br Med Bull. 2013;105:43-68.
62. Caruso M, Evangelista M, Parolini O. Human term placental cells: phenotype, properties, and new avenues in regenerative medicine. Int J Mol Cell Med. 2012;1(2):64-74.
63. Strakova Z, Livak M, Krezalek M, Ihnatovych I. Multipotent properties of myofibroblast cells derived from human placenta. Cell Tissue Res. 2008;332(3):479-88.
64. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008;17(6):1095-107.
65. Huang YC, Yang ZM, Chen XH, Tan MY, Wang J, Li XQ, et al. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. 2009;5(3):247-55.
66. Castrechini NM, Murthi P, Qin S, Kusuma GD, Wilton L, Abumaree M, et al. Decidua parietalis-derived mesenchymal stromal cells reside in a vascular niche within the choriodecidua. Reprod Sci. 2012;19(12):1302-14.
67. Macias MI, Grande J, Moreno A, Dominguez I, Bornstein R, Flores AI. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010;203(5):495e9-23.
68. Hayati AR, Nur Fariha MM, Tan GC, Tan AE, Chua K. Potential of human decidua stem cells for angiogenesis and neurogenesis. Arch Med Res. 2011;42(4):291-300.
69. Bornstein R, Macias MI, de la Torre P, Grande J, Flores AI. Human decidua-derived mesenchymal stromal cells differentiate into hepatic-like cells and form functional three-dimensional structures. Cytotherapy. 2012;14(10):1182-92.
70. Sabapathy V, Ravi S, Srivastava V, Srivastava A, Kumar S. Longterm cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int. 2012; 2012:174328-38.
71. Lu GH, Yong WS, Xu ZM, Ke YQ, Jiang XD, Zhang SZ. Human placental decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells with no response to longterm culture in vitro. Neuroreport. 2012;23(8):513-8.
72. Kanematsu D, Shofuda T, Yamamoto A, Ban C, Ueda T, Yamasaki M, et al. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation. 2011;82(2):77-88.
73. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, et al. Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol. 2010;202(2): 193e1-13.
74. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005;23(1):3-9.
75. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int. 2006;30(9):681-7.
76. Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH, et al. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells. 2006;24(7):1759-68.
77. Zhang Y, Li C, Jiang X, Zhang S, Wu Y, Liu B, et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol. 2004;32(7):657-64.
78. Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, AlTalabani AA, et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev. 2013;9(1):16-31.
79. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007;75(4):279-91.
80. Martini MM, Jeremias Tda S, Kohler MC, Marostica LL, Trentin AG, Alvarez-Silva M. Human placenta-derived mesenchymal stem cells acquire neural phenotype under the appropriate niche conditions. DNA Cell Biol. 2013;32(2):58-65.
81. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, et al. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun. 2006;340(3):944-52.
82. Nazarov I, Lee JW, Soupene E, Etemad S, Knapik D, Green W, et al. Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med. 2012; 1(5):359-72.
83. Marongiu F, Gramignoli R, Sun Q, Tahan V, Miki T, Dorko K, et al. Isolation of amniotic mesenchymal stem cells. Curr Protoc Stem Cell Biol. 2010;Chapter 1:Unit 1E 5.
84. Paracchini V, Carbone A, Colombo F, Castellani S, Mazzucchelli S, Gioia SD, et al. Amniotic mesenchymal stem cells: A new source for hepatocyte-like cells and induction of CFTR expression by coculture with cysticfibrosis airway epithelial cells. J Biomed Biotechnol. 2012;2012:575471-85.
85. Bacenkova D, Rosocha J, Tothova T, Rosocha L, Sarissky M. Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells. Cytotherapy. 2011;13(9): 1047-56.
86. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation. 2004;78(10): 1439-48.
87. Jones GN, Moschidou D, Puga-Iglesias TI, Kuleszewicz K, Vanleene M, Shefelbine SJ, et al. Ontological differences infirst compared to third trimester human fetal placental chorionic stem cells. PLoS One. 2012;7(9):e43395.
88. Koo BK, Park IY, Kim J, Kim JH, Kwon A, Kim M, et al. Isolation and characterization of chorionic mesenchymal stromal cells from human full term placenta. J Korean Med Sci. 2012;27(8):857-63.
89. Cavallo C, Cuomo C, Fantini S, Ricci F, Tazzari PL, Lucarelli E, et al. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem. 2011;112(5):1418-30.
90. Nogami M, Tsuno H, Koike C, Okabe M, Yoshida T, Seki S, et al. Isolation and characterisation of human amniotic mesenchymal stem cells and their chondrogenic differentiation. Transplantation. 2012;93(12):1221-8.
91. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res. 2004;78(2): 208-14.
92. Chang YJ, Hwang SM, Tseng CP, Cheng FC, Huang SH, Hsu LF, et al. Isolation of mesenchymal stem cells with neurogenic potential from the mesoderm of the amniotic membrane. Cells Tissues Organs. 2010;192(2):93-105.
93. Park A, Chan L, Gohel MDI, Murphy S, Manuelpillai U, Chidgey A, et al. Newborn stem cells: identity, function and clinical potential. In: Cetrulo KJ, Cetrulo CL, Taghizadeh RR, editors. Perinatal stem cells. Hoboken, NJ: Wiley; 2013. p. 119-38.
94. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007;7:11-24.
95. Ryan JM, Pettit AR, Guillot PV, Chan JK, Fisk NM. Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of the emperor's new clothes. Stem Cell Rev. 2013;9(4):408-21.
96. Magatti M, De Munari S, Vertua E, Gibelli L, Wengler GS, Parolini O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2008;26(1):182-92.
97. Magatti M, De Munari S, Vertua E, Parolini O. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. J Cell Mol Med. 2012;16(9):2208-18.
98. Rossi D, Pianta S, Magatti M, Sedlmayr P, Parolini O. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. Plos One. 2012;7(10):e46956.
99. Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amnioticfluid-derived cells: potential tools for regenerative medicine? Regen Med. 2009;4(2):275-91.
100. Lu G, Zhu S, Ke Y, Jiang X, Zhang S. Transplantation-potentialrelated biological properties of decidua basalis mesenchymal stem cells from maternal human term placenta. Cell Tissue Res. 2013;352(2):301-12.
101. Chen M, Wang X, Ye Z, Zhang Y, Zhou Y, Tan WS. A modular approach to the engineering of a centimeter-sized bone tissue construct with human amniotic mesenchymal stem cells-laden microcarriers. Biomaterials. 2011;32(30):7532-42.
102. Zhang D, Tong A, Zhou L, Fang F, Guo G. Osteogenic differentiation of human placenta-derived mesenchymal stem cells (PMSCs) on electrospun nanofiber meshes. Cytotechnology. 2012;64(6): 701-10.
103. Bertoldi S, Fare S, Denegri M, Rossi D, Haugen HJ, Parolini O, et al. Ability of polyurethane foams to support placenta-derived cell adhesion and osteogenic differentiation: preliminary results. J Mater Sci Mater Med. 2010;21(3):1005-11.
104. Wei JP, Nawata M, Wakitani S, Kametani K, Ota M, Toda A, et al. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells. 2009;11(1):19-26.
105. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation. 2005;79(5):528-35.
106. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I, et al. Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem. 2007;282(19):14243-52.
107. Lisi A, Briganti E, Ledda M, Losi P, Grimaldi S, Marchese R, et al. A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS One. 2012;7(4):e34284.
108. Chen L, He DM, Zhang Y. The differentiation of human placentaderived mesenchymal stem cells into dopaminergic cells in vitro. Cell Mol Biol Lett. 2009;14(3):528-36.
109. Park S, Koh SE, Maeng S, Lee WD, Lim J, Lee YJ. Neural progenitors generated from the mesenchymal stem cells offirsttrimester human placenta matured in the hypoxic-ischemic rat brain and mediated restoration of locomotor activity. Placenta. 2011;32(3):269-76.
110. Park S, Kim E, Koh SE, Maeng S, Lee WD, Lim J, et al. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior. Brain Res. 2012;1466:158-66.
111. Orza A, Soritau O, Olenic L, Diudea M, Florea A, Rus Ciuca D, et al. Electrically conductive gold-coated collagen nanofibers for placental-derived mesenchymal stem cells enhanced differentiation and proliferation. ACS Nano. 2011;5(6):4490-503.
112. Parolini O, Caruso M. Review: preclinical studies on placentaderived cells and amniotic membrane: an update. Placenta. 2011;32 Suppl 2:S186-95.
113. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell. 2007;20(3):77-84.
114. Cao H, Yang J, Yu J, Pan Q, Li J, Zhou P, et al. Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure. BMC Med. 2012;10:56-75.
115. Tamagawa T, Ishiwata I, Sato K, Nakamura Y. Induced in vitro differentiation of pancreatic-like cells from human amnion derivedfibroblast-like cells. Hum Cell. 2009;22(3):55-63.
116. Kim J, Park S, Kang HM, Ahn CW, Kwon HC, Song JH, et al. Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression. Cell Transplant. 2012;21(10):213-47.
117. Lee MY, Huang JP, Chen YY, Aplin JD, Wu YH, Chen CY, et al. Angiogenesis in differentiated placental multipotent mesenchymal stromal cells is dependent on integrinalpha5beta1. PLoS One. 2009;4(10):e6913.
118. Kim SW, Zhang HZ, Guo L, Kim JM, Kim MH. Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One. 2012;7(10):e41105.
119. König J, Huppertz B, Desoye G, Parolini O, Fröhlich JD, Weiss G, et al. Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells. Stem Cells Dev. 2012;21(8):1309-20.
120. Midgley AR, Pierce Jr GB, Deneau GA, Gosling JR. Morphogenesis of syncytiotrophoblast in vivo: an autoradiographic demonstration. Science. 1963;141(3578):349-50.
121. Desforges M, Parsons L, Westwood M, Sibley CP, Greenwood SL. Taurine transport in human placental trophoblast is important for regulation of cell differentiation and survival. Cell Death Dis. 2013;4:e559.
122. Takao T, Asanoma K, Kato K, Fukushima K, Tsunematsu R, Hirakawa T, et al. Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line. PLoS One. 2011;6(7):e21990.
123. Ringler GE, Strauss 3rd JF. In vitro systems for the study of human placental endocrine function. Endocr Rev. 1990;11(1):105-23.
124. James JL, Stone PR, Chamley LW. The isolation and characterization of a population of extravillous trophoblast progenitors fromfirst trimester human placenta. Hum Reprod. 2007;22(8):2111-9.
125. Loke YW, Gardner L, Grabowska A. Isolation of human extravillous trophoblast cells by attachment to laminin-coated magnetic beads. Placenta. 1989;10(4):407-15.
126. Burrows TD, King A, Loke YW. Expression of integrins by human trophoblast and differential adhesion to laminin orfibronectin. Hum Reprod. 1993;8(3):475-84.
127. Kliman HJ, Feinberg RF. Human trophoblast-extracellular matrix (ECM) interactions in vitro: ECM thickness modulates morphology and proteolytic activity. Proc Natl Acad Sci U S A. 1990;87(8):3057-61.
128. Yui J, Garcia-Lloret M, Brown AJ, Berdan RC, Morrish DW, Wegmann TG, et al. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta. 1994;15(3):231-46.
129. Aboagye-Mathiesen G, Laugesen J, Zdravkovic M, Ebbesen P. Isolation and characterization of human placental trophoblast subpopulations fromfirst-trimester chorionic villi. Clin Diagn Lab Immunol. 1996;3(1):14-22.
130. Spitalieri P, Cortese G, Pietropolli A, Filareto A, Dolci S, Klinger FG, et al. Identification of multipotent cytotrophoblast cells from humanfirst trimester chorionic villi. Cloning Stem Cells. 2009;11(4):535-56.
131. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 1991;113(2):437-49.
132. Douglas GC, King BF. Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. J Immunol Methods. 1989;119(2):259-68.
133. Petroff MG, Phillips TA, Ka H, Pace JL, Hunt JS. Isolation and culture of term human trophoblast cells. Methods Mol Med. 2006;121:203-17.
134. Contractor SF, Sooranna SR. Human placental cells in culture: A panning technique using a trophoblast-specific monoclonal antibody for cell separation. J Dev Physiol. 1988;10(1):47-51.
135. Kawata M, Parnes JR, Herzenberg LA. Transcriptional control of HLA-A, B, C antigen in human placental cytotrophoblast isolated using trophoblast-and HLA-specific monoclonal antibodies and thefluorescence-activated cell sorter. J Exp Med. 1984;160(3):633-51.
136. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 1996;97(2):540-50.
137. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss 3rd JF. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology. 1986;118(4):1567-82.
138. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, et al. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol. 1989;109(2):891-902.
139. Silini A, Parolini O, Huppertz B, Lang I. Soluble factors of amnion-derived cells in treatment of inflammatory andfibrotic pathologies. Curr Stem Cell Res Ther. 2013;8(1):6-14.
140. Parolini O, Soncini M. Placenta as a source of stem cells and as a key organ for fetomaternal tolerance. In: Regenerative medicine using pregnancy-specific biological substances. London: Springer; 2011. p. 11-23.
141. Jang MJ, Kim HS, Lee HG, Kim GJ, Jeon HG, Shin HS, et al. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice. Acta Haematol. 2013;129(4):197-206.
142. Yuge I, Takumi Y, Koyabu K, Hashimoto S, Takashima S, Fukuyama T, et al. Transplanted human amniotic epithelial cells express connexin 26 and Na-K-adenosine triphosphatase in the inner ear. Transplantation. 2004;77(9):1452-4.
143. Meng XT, Li C, Dong ZY, Liu JM, Li W, Liu Y, et al. Co-transplantation of bFGF-expressing amniotic epithelial cells and neural stem cells promotes functional recovery in spinal cordinjured rats. Cell Biol Int. 2008;32(12):1546-58.
144. Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience. 2003;118(1):11-7.
145. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110(10):3499-506.
146. Banas RA, Trumpower C, Bentlejewski C, Marshall V, Sing G, Zeevi A. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol. 2008;69(6):321-8.
147. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007;13(6):1173-83.
148. Luan X, Li G, Wang G, Wang F, Lin Y. Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34(+) cells: A comparison with human bone marrow-derived mesenchymal stem cells. Tissue Cell. 2013;45(1):32-8.
149. Li C, Zhang W, Jiang X, Mao N. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell Tissue Res. 2007;330(3):437-46.
150. Vellasamy S, Sandrasaigaran P, Vidyadaran S, George E, Ramasamy R. Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells. 2012;4(6):53-61.
151. Chang CJ, Yen ML, Chen YC, Chien CC, Huang HI, Bai CH, et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells. 2006;24(11):2466-77.
152. Manochantr S, Up Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, et al. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Intern Med J. 2013;43(4):430-9.
153. Yang ZX, Han ZB, Ji YR, Wang YW, Liang L, Chi Y, et al. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One. 2013;8(3):e59354.
154. Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, McCulley JP, et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci. 2005;46(3):900-7.
155. Gu YZ, Xue Q, Chen YJ, Yu GH, Qing MD, Shen Y, et al. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells. Hum Immunol. 2013;74(3):267-76.
156. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-52.
157. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419-26.
158. Magatti M, De Munari S, Vertua E, Nassauto C, Albertini A, Wengler GS, et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009;18(8):899-914.
159. Tan JL, Chan ST, Wallace EM, Lim R. Human amnion epithelial cells mediate lung repair by directly modulating macrophage recruitment and polarization. Cell Transplant. 2014;23(3): 319-28.